The anti-CAR Whitlow linker peptide 1H5b clone has been developed to detect cells expressing Whitlow linker-containing CARs with different antigen specificities, including those harbouring the widely employed anti-CD19 FMC63-derived scFv as well as other scFvs, such as those targeting B-cell maturation antigen (BCMA) or CD33. It has been demonstrated to have a mean KD of […]
| Inventor | Institute |
|---|---|
| Erik Kimble, Jocelyn Wright | Fred Hutchinson Cancer Center |
| Cat. #: | 162438 |
|---|---|
| Unit size: | 1 mg |
| Application: | Flow cytometry |
| Target: | Chimeric antigen receptor Whitlow scFv peptide linker |
| Clone: | 1H5B |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Kimble et al. 2025.J Immunother Cancer. 2025 Nov 18;13(11):e013123. PMID: 41253497 |
| Product description: | The anti‑CAR Whitlow linker peptide 1H5b clone is a murine monoclonal antibody that detects cells expressing Whitlow linker‑containing CARs with different antigen specificities, including those harbouring the FMC63‑derived anti‑CD19 scFv as well as other scFvs such as those targeting CD33. It has a mean KD of approximately 0.10 µM for FMC63‑Whitlow scFv protein and 0.11 µM for the Whitlow peptide, with no observable binding to the G4S4 peptide. In flow cytometry, 1H5b stains engineered T cells expressing FMC63‑ or 1H7‑Whitlow CARs, but not the corresponding FMC63‑ or 1H7‑G4S CARs. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Synthetic Whitlow peptide |
| Target background: | While CAR T-cell therapies have revolutionized the treatment of B-lineage malignancies, high-resolution tracking of CAR-engineered cells within the tumor microenvironment (TME) remains a significant technical challenge, particularly in archival formalin-fixed paraffin-embedded (FFPE) tissues. To address this, murine monoclonal antibodies (mAbs) have been developed to specifically target the Whitlow linker, a synthetic peptide commonly utilized in the scFv domains of multiple FDA-approved CAR products (e.g., axi-cel, liso-cel). Because this linker is absent in native human tissue and conserved across various antigen specificities, these mAbs provide a universal tool for the in situ identification, selection, and functional analysis of CAR-expressing cells. This methodology enables a more precise evaluation of CAR T-cell infiltration, persistence, and correlation with clinical outcomes or toxicities. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.